Aberrations of EZH2 in Cancer von CHASE, Andrew, CROSS, Nicholas C. P

Volltext

DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia von Mistry, Anita R, Felix, Carolyn A, Whitmarsh, Ryan J, Mason, Annabel, Reiter, Andreas, Cassinat, Bruno, Parry, Anne, Walz, Christoph, Wiemels, Joseph L, Segal, Mark R, Adès, Lionel, Blair, Ian A, Osheroff, Neil, Peniket, Andrew J, Lafage-Pochitaloff, Marina, Cross, Nicholas C.P, Chomienne, Christine, Solomon, Ellen, Fenaux, Pierre, Grimwade, David

Volltext

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia von ITZYKSON, Raphaël, KOSMIDER, Olivier, VEY, Norbert, BRAUN, Thorsten, HAFERLACH, Torsten, DREYFUS, François, CROSS, Nicholas C. P, PREUDHOMME, Claude, BERNARD, Olivier A, FONTENAY, Michaela, VAINCHENKER, William, SCHNITTGER, Susanne, RENNEVILLE, Aline, BIRNBAUM, Daniel, DROIN, Nathalie, SOLARY, Eric, GELSI-BOYER, Véronique, MEGGENDORFER, Manja, MORABITO, Margot, BERTHON, Céline, ADES, Lionel, FENAUX, Pierre, BEYNE-RAUZY, Odile

Volltext

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders von Cross, Nicholas C P, Ernst, Thomas, Chase, Andrew J, Score, Joannah, Hidalgo-Curtis, Claire E, Bryant, Catherine, Jones, Amy V, Waghorn, Katherine, Zoi, Katerina, Ross, Fiona M, Reiter, Andreas, Hochhaus, Andreas, Drexler, Hans G, Duncombe, Andrew, Cervantes, Francisco, Oscier, David, Boultwood, Jacqueline, Grand, Francis H

Volltext

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer von Forsberg, Lars A, Rasi, Chiara, Malmqvist, Niklas, Davies, Hanna, Pasupulati, Saichand, Pakalapati, Geeta, Sandgren, Johanna, de Ståhl, Teresita Diaz, Zaghlool, Ammar, Giedraitis, Vilmantas, Lannfelt, Lars, Score, Joannah, Cross, Nicholas C P, Absher, Devin, Janson, Eva Tiensuu, Lindgren, Cecilia M, Morris, Andrew P, Ingelsson, Erik, Lind, Lars, Dumanski, Jan P

Volltext

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia von Piazza, Rocco, Valletta, Simona, Winkelmann, Nils, Redaelli, Sara, Spinelli, Roberta, Pirola, Alessandra, Antolini, Laura, Mologni, Luca, Donadoni, Carla, Papaemmanuil, Elli, Schnittger, Susanne, Kim, Dong-Wook, Boultwood, Jacqueline, Rossi, Fabio, Gaipa, Giuseppe, De Martini, Greta P, di Celle, Paola Francia, Jang, Hyun Gyung, Fantin, Valeria, Bignell, Graham R, Magistroni, Vera, Haferlach, Torsten, Pogliani, Enrico Maria, Campbell, Peter J, Chase, Andrew J, Tapper, William J, Cross, Nicholas C P, Gambacorti-Passerini, Carlo

Volltext

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms von Tapper, William, Jones, Amy V., Kralovics, Robert, Harutyunyan, Ashot S., Zoi, Katerina, Leung, William, Godfrey, Anna L., Guglielmelli, Paola, Callaway, Alison, Ward, Daniel, Aranaz, Paula, White, Helen E., Waghorn, Katherine, Lin, Feng, Chase, Andrew, Joanna Baxter, E., Maclean, Cathy, Nangalia, Jyoti, Chen, Edwin, Evans, Paul, Short, Michael, Jack, Andrew, Wallis, Louise, Oscier, David, Duncombe, Andrew S., Schuh, Anna, Mead, Adam J., Griffiths, Michael, Ewing, Joanne, Gale, Rosemary E., Schnittger, Susanne, Haferlach, Torsten, Stegelmann, Frank, Döhner, Konstanze, Grallert, Harald, Strauch, Konstantin, Tanaka, Toshiko, Bandinelli, Stefania, Giannopoulos, Andreas, Pieri, Lisa, Mannarelli, Carmela, Gisslinger, Heinz, Barosi, Giovanni, Cazzola, Mario, Reiter, Andreas, Harrison, Claire, Campbell, Peter, Green, Anthony R., Vannucchi, Alessandro, Cross, Nicholas C.P.

Volltext

Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis von Jones, Amy V, Cross, Nicholas C.P, White, Helen E, Green, Anthony R, Scott, Linda M

Volltext

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms von Wang, Y Lynn, Zoi, Katerina, Pahl, Heike L, Cario, Holger, Reiter, Andreas, Jones, Amy V, Collins, Andrew, Grand, Francis, Silver, Richard T, Chase, Andrew, Cross, Nicholas C P, Oscier, David

Volltext

Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib von Cheah, Chan Y., Burbury, Kate, Apperley, Jane F., Huguet, Francoise, Pitini, Vincenzo, Gardembas, Martine, Ross, David M., Forrest, Donna, Genet, Philippe, Rousselot, Philippe, Patton, Nigel, Smith, Graeme, Dunbar, Cynthia E., Ito, Sawa, Ricardo Aguiar, C.T., Odenike, Olatoyosi, Gimelfarb, Alla, Nicholas Cross, C.P., John Seymour, F.

Volltext

The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm von Jawhar, Mohamad, Schwaab, Juliana, Meggendorfer, Manja, Naumann, Nicole, Horny, Hans-Peter, Sotlar, Karl, Haferlach, Torsten, Schmitt, Karla, Fabarius, Alice, Valent, Peter, Hofmann, Wolf-Karsten, Cross, Nicholas C P, Metzgeroth, Georgia, Reiter, Andreas

Volltext

Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case von Chiecchio, Laura, Dagrada, Gian Paolo, Protheroe, Rebecca K.M, Stockley, David M, Smith, Alastair G, Orchard, Kim H, Cross, Nicholas C.P, Harrison, Christine J, Ross, Fiona M, on behalf of UK Myeloma Forum

Volltext

Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable von Zoi, Katerina, Cross, Nicholas C. P.

Volltext

Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic Myeloproliferative Diso... von Chen, Qiaofang, Lu, Pin, Jones, Amy V, Cross, Nicholas C.P, Silver, Richard T, Wang, Y. Lynn

Volltext

A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy von Grand, Francis H, Iqbal, Sameena, Zhang, Lingyan, Russell, Nigel H, Chase, Andrew, Cross, Nicholas C.P

Volltext

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative ne... von Mughal, Tariq I, Cross, Nicholas C P, Padron, Eric, Tiu, Ramon V, Savona, Michael, Malcovati, Luca, Tibes, Raoul, Komrokji, Rami S, Kiladjian, Jean-Jacques, Garcia-Manero, Guillermo, Orazi, Attilio, Mesa, Ruben, Maciejewski, Jaroslaw P, Fenaux, Pierre, Itzykson, Raphael, Mufti, Ghulam, Solary, Eric, List, Alan F

Volltext

Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms von Jones, Amy V, Ward, Daniel, Lyon, Matthew, Leung, William, Callaway, Alison, Chase, Andrew, Dent, Carolyn L, White, Helen E, Drexler, Hans G, Nangalia, Jyoti, Mattocks, Chris, Cross, Nicholas C.P

Volltext

Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome von Chase, Andrew, Bryant, Catherine, Score, Joannah, Cross, Nicholas C P

Volltext

A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome von Cools, Jan, DeAngelo, Daniel J, Gotlib, Jason, Stover, Elizabeth H, Legare, Robert D, Cortes, Jorges, Kutok, Jeffrey, Clark, Jennifer, Galinsky, Ilene, Griffin, James D, Cross, Nicholas C.P, Tefferi, Ayalew, Malone, James, Alam, Rafeul, Schrier, Stanley L, Schmid, Janet, Rose, Michal, Vandenberghe, Peter, Verhoef, Gregor, Boogaerts, Marc, Wlodarska, Iwona, Kantarjian, Hagop, Marynen, Peter, Coutre, Steven E, Stone, Richard, Gilliland, D. Gary

Volltext

Standardisation of molecular monitoring for chronic myeloid leukaemia von Cross, Nicholas C.P., MA, PhD, FRCPath

Volltext